Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGattaca Regulatory News (GATC)

Share Price Information for Gattaca (GATC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 92.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 2.00 (2.198%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 92.00
GATC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

17 Aug 2021 07:00

RNS Number : 8021I
Gattaca PLC
17 August 2021
 

17 August 2021

 

Gattaca plc

("Gattaca", "the Group" or "the Company")

 

Trading Update for 12 months ended 31 July 2021

Performance ahead of expectations

 

 

Gattaca plc (LSE-AIM: GATC), the UK's leading specialist Engineering and Technology staffing business, today provides the following trading update for the 12 months ended 31 July 2021.

 

Following our trading update announcement on 21 May 2021, we expect continuing underlying PBT1 and adjusted net cash (excluding IFRS16 lease liabilities) to be above market expectations for FY 2021.

 

H2 2021 continuing Net Fee Income ("NFI") was 7% higher than H1 2021, with the full year NFI at £42.5m (FY 2020: £52.8m), reflecting the market impact of the COVID-19 pandemic over the entire reporting period.

 

We continue to add sales and delivery resource across the business, increasing front line headcount by 13% since January whilst tightly managing the overall cost base.

 

Consequently, subject to final adjustments and audit, we expect our continuing underlying PBT for the full year to be in excess of £3m (market consensus £2.7m).

 

Adjusted Net Cash (excluding IFRS16 lease liabilities) is expected to be £20m2 (31 July 2020: £27m) largely driven by repayment of deferred VAT (£4.7m)

 

All of our businesses successfully transferred to our global technology platform in Q4 enabling the business to have a consistent view of activity and performance across all of our operating units. 

We have seen increased activity from our "RPO" (Permanent Recruitment Process Outsourcing solutions) clients as the market recovery has been led by permanent recruitment both in contingent and solutions products. There is further improvement to come on the contract front including in our core infrastructure unit, which will benefit from strong demand driven by major initiatives such as UK Fibre investment, HS2 and Offshore 2025, which we are seeing already positively impacting hiring. Our defence business continues to perform strongly. We also anticipate continuing high demand for technology skills as the pace of digitisation continues to accelerate.

 

We have determined that our sales operations in Mexico and South Africa are sub-scale and we exited both at the end of July and these businesses will be treated as discontinued in our FY 2021 results.

 

In light of the improved performance and assuming a continuation of the current positive trends, the Board anticipates the recommendation of a modest dividend when the full year results are announced.

 

The Group expects to announce its full year results for the 12 months to 31 July 2021 on Thursday 4 November 2021.

 

 

 

Kevin Freeguard, Chief Executive Officer said:

 

"Following our upgrade in May, I am pleased that our profit results will again be ahead of expectations. Whilst the pandemic continues to impact activity across our markets, it is clear that we have now entered the next phase of recovery. Our new global technology platform will increase our ability to collaborate and drive performance across the business. At the same time, our continued investment in sales and delivery resources will enable us to capitalise on the continuing opportunities as our markets, including Infrastructure and Defence, emerge from the pandemic."

 

1 Continuing underlying results exclude the NFI and (losses) / profits before taxation of discontinued operations. The combined NFI of Mexico and South Africa in the year was £1.0m and losses before tax were £(0.2)m (2020: NFI £1.5m and profit before tax £0.2m

2 VAT deferrals at 31 July 2021 were £5.6m (31 July 2020: £10.3m)

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

For further information please contact:

Gattaca plc

+44 (0) 1489 898989

Kevin Freeguard, Chief Executive Officer

Salar Farzad, Chief Financial Officer

 

 

Liberum Capital Limited (Nomad and Broker)

+44 (0) 20 3100 2000

Lauren Kettle

Robert Morton

Euan Brown

 

 

 

Citigate Dewe Rogerson

+44 (0) 20 7638 9571

Jos Bieneman

Elizabeth Kittle

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEQLFFFVLFBBX
Date   Source Headline
5th Aug 20149:49 amRNSDirector/PDMR Shareholding
1st Aug 201410:29 amRNSDirector/PDMR Shareholding
30th Jun 20144:41 pmRNSDirector/PDMR Shareholding
26th Jun 20145:10 pmRNSDirector/PDMR Shareholding
16th Jun 20142:44 pmRNSResignation of Non-Executive Director
22nd Apr 20143:34 pmRNSDirector/PDMR Shareholding
8th Apr 20141:34 pmRNSAward under the Value Creation Plan
8th Apr 20147:00 amRNSHalf Yearly Report
6th Feb 20147:00 amRNSPre-close Trading Update
27th Jan 20144:30 pmRNSGrant of Share Options
22nd Jan 20141:46 pmRNSBlocklisting Application
20th Dec 20135:54 pmRNSDirector/PDMR Shareholding
13th Dec 201311:06 amRNSDirector/PDMR Shareholding
29th Nov 20137:00 amRNSDirector/PDMR Shareholding
20th Nov 20137:00 amRNSDirector/PDMR Shareholding
15th Nov 20132:11 pmRNSResult of AGM
15th Nov 20137:00 amRNSAGM Statement
25th Oct 20137:00 amRNSAnnual Report and Accounts
24th Oct 20135:55 pmRNSBLOCK LISTING SIX MONTHLY RETURN
15th Oct 20135:49 pmRNSDirector/PDMR Shareholding
15th Oct 20137:00 amRNSFinal Results
20th Sep 20137:00 amRNSDirectorate Change
20th Sep 20137:00 amRNSCash Placing
6th Sep 20137:00 amRNSAcquisition
8th Aug 20137:00 amRNSPre-close Trading Update
16th Jul 201311:50 amRNSDirector/PDMR Shareholding
11th Apr 20137:00 amRNSHalf Yearly Report
14th Mar 20137:00 amRNSMajor Contract Extension and New Contract Win
20th Feb 201310:49 amRNSBlocklisting Interim Review
13th Feb 20133:28 pmRNSBlocklisting Application
7th Feb 20137:00 amRNSTrading Statement
6th Feb 20138:44 amRNSGrant of Share Options
31st Jan 20132:40 pmRNSAnnual Report and Accounts - Replacement
31st Jan 201311:07 amRNSAnnual Report and Accounts
10th Jan 20134:34 pmRNSDirector/PDMR Shareholding
17th Dec 20123:20 pmRNSHolding(s) in Company
16th Nov 20123:18 pmRNSResult of AGM
16th Nov 20127:00 amRNSAGM Statement
12th Oct 20129:46 amRNSDirector/PDMR Shareholding
4th Oct 20127:00 amRNSFinal Results
6th Sep 20127:00 amRNSBoard Appointment
2nd Aug 20127:00 amRNSTrading Statement
11th Apr 20127:00 amRNSHalf Yearly Report
1st Mar 20127:00 amRNSBoard Appointment
2nd Feb 20127:00 amRNSPre-close Trading Update
30th Jan 20127:00 amRNSChange of Adviser
10th Jan 20123:54 pmRNSBlocklisting Interim Review
10th Jan 20123:53 pmRNSDirector/PDMR Shareholding
21st Nov 20119:14 amRNSAwards under the Value Creation Plan
18th Nov 20113:07 pmRNSResult of Annual General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.